-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
-
Summary
-
Esperion Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2014 to 2024.
- Esperion Therapeutics, Inc. Return On Assets for the quarter ending March 31, 2025 was -45.9 %, a 37.4% decline year-over-year.
- Esperion Therapeutics, Inc. annual Return On Assets for 2024 was -15 %, a 83.7% increase from 2023.
- Esperion Therapeutics, Inc. annual Return On Assets for 2023 was -91.6 %, a 18.4% decline from 2022.
- Esperion Therapeutics, Inc. annual Return On Assets for 2022 was -77.4 %, a 16.2% increase from 2021.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)